Why the study?
Does multiple electrode impedance aggregometry in whole blood provide similar platelet aggregation results compared to light transmission aggregometry in PRP in patients with Glanzmann thrombasthenia?
Does multiple electrode impedance aggregometry in whole blood provide similar platelet aggregation results compared to light transmission aggregometry in PRP in patients with Glanzmann thrombasthenia?
Multiple electrode aggregometry in whole blood provides similar results to traditional light transmission aggregometry in platelet-rich plasma for evaluating Glanzmann thrombasthenia, while being faster and more convenient.
May support whole blood aggregometry for Glanzmann thrombasthenia evaluation; leaves open larger prospective validation.
We examined platelet aggregation in platelet-rich plasma (PRP) and in whole blood in nine patients with Thrombasthenia Glanzmann (TG). In PRP, aggregation was measured by monitoring the changes in light absorbance that occurred in response to adenosine 5-diphosphate (ADP), collagen and ristocetin. To measure platelet aggregation in whole blood, we used multiple electrode Impedance aggregometry using the same aggregating agents. In PRP, the patient's platelets showed defective aggregation in response to ADP, collagen, epinephrine and partially to ristocetin in all patients. In whole blood, platelet aggregation in response to the same aggregating agents showed similar response and appeared to be very similar to that which occurred in PRP. Whole blood impedance aggregometry seems to give similar results to PRP light transmission aggregometry in patients with TG. Multiple electrode aggregometry (MEA) is faster and more convenient to use in these patients.
No takes yet. Share an insight, caveat, or question.
Awidi et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: